News: PBP Probiotec Expects FY22 Underlying EBITDA Of A$32 Mln-A$33 Mln

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 25 (Reuters) - Probiotec Ltd (PBP) :

    • FY22 GUIDANCE UPDATE
    • SEES FY22 REVENUE OF BETWEEN A$175 MILLION AND A$180 MILLION
    • SEES FY22 UNDERLYING EBITDA OF BETWEEN A$32 MILLION AND A$33 MILLION
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.